Screening of Latent Tuberculous Infection (LTBI) before starting anti-tumor necrosis factor therapy in patients with psoriasis: A primer for clinical dermatologist
Anti-tumor necrosis agents are being increasingly used in the management of moderate to severe psoriasis. Therapy with antitumor necrosis factor alpha (TNF-α) agents is being fraught with reactivation of latent tuberculosis infection (LTBI). This paper addresses the intricate relation between LTBI a...
Saved in:
Main Authors: | Swetalina Pradhan (Author), Bhushan Madke (Author), Shekhar Neema (Author), Poonam Kabra (Author), Adarsh Lata Singh (Author), Sangita Yadav (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anti-inflammatory and immunomodulatory effects of antibiotics and their use in dermatology
by: Swetalina Pradhan, et al.
Published: (2016) -
Less-known clinical signs in dermatology
by: Swetalina Pradhan, et al.
Published: (2016) -
Prevalence of latent tuberculosis infection among participants of the national LTBI screening program in South Korea - A problem of low coverage rate with current LTBI strategy
by: Hyung Woo Kim, et al.
Published: (2023) -
Insights into culturally appropriate latent tuberculosis infection (LTBI) screening in NSW: perspectives of Indian and Pakistani migrants
by: Julie Hall, et al.
Published: (2020) -
Integrated Care for Latent Tuberculosis Infection (LTBI) at a Primary Health Care Facility for Refugees in Winnipeg, Canada: A Mixed-Methods Evaluation
by: Dione Benjumea-Bedoya, et al.
Published: (2019)